J7Z Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Jazz Pharmaceuticals PLC

Watchlist Manager

Watchlist

Price: 180.9 EUR 1.8% Market Closed

Market Cap: €11.4B

J	Jazz Pharmaceuticals PLC SWB:J7Z	IE
	Marinus Pharmaceuticals Inc F:61Y	US
A	Astroscale Holdings Inc TSE:186A	JP
O	Orion Energy Systems Inc XBER:5A4	US
I	Iovance Biotherapeutics Inc LSE:0JDK	US
	PT Bank Neo Commerce Tbk IDX:BBYB	ID
	China Haisum Engineering Co Ltd SZSE:002116	CN
	D&L Industries Inc OTC:DALQF	PH
H	Hiscox Ltd SWB:H2X3	BM
C	Cassava Sciences Inc SWB:PX91	US
T	Tata Technologies Ltd BSE:544028	IN
	Bumi Serpong Damai Tbk PT IDX:BSDE	ID
C	Cenovus Energy Inc NYSE:CVE	CA
	Cavendish Hydrogen ASA F:V07	NO
G	Globus Medical Inc XBER:GM0N	US

Profitability Summary

Jazz Pharmaceuticals PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

86% > 88%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

1% > 18%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-2% > 1%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

28%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.